Publications
Publications and resources from the Powder Diffraction beamline.
Showing 1241 - 1260 of 1508 results
Publications and resources from the Powder Diffraction beamline.
Dr Klaus Wilcken is an accelerator mass spectrometry scientist at the Centre for Accelerator Science (CAS) with over 12 years of experience with suite of AMS isotopes & techniques.
The Detection & Imaging group builds on ANSTO’s 70-year history of scientific achievements and contributions in meeting the nuclear needs of industry, globally.
A large group of ANSTO environmental scientists and collaborators have produced the first groundwater stable isotopes, ‘isoscapes’, intuitive maps with grid data, across NSW combining new and pre-existing isotope measurements.
It's ANSTO's role to keep Australia across the very latest developments in nuclear science and technology from around the world. Part of this responsibility is keeping us abreast of the latest developments in nuclear power technologies.
Highly accurate non-invasive nuclear technique helps validate theoretical model for optimised laser material deposition in additive manufacturing.
The Panel Pledge aims to increase the visibility and contribution of women and diverse leaders in public and professional forums.
Study reveals that properties of polycrystalline materials can be derived from microscopic single crystal samples
ANSTO is part of collaboration conducting experiments to redefine the kilogram linking it to a fundamental constant of nature.
ANSTO contributes to new international project to improve how the world assesses the economic viability of Small Modular Reactors
A “super” receptor that helps kill HIV infected cells identified.
ANSTO is taking its innovative ANSTO Synroc® and CORIS360® technologies to the world stage at the Waste Management Symposia 2024 in Phoenix, Arizona USA this week (10 – 14 March 2024). Joining over 45 other countries and around 3,000 attendees, an Australian Government contingent comprising of ANSTO and the Australian Radioactive Waste Agency is in attendance to showcase Australia’s extensive radioactive waste management capabilities.
The Australian Synchrotron has played a crucial role in the discovery of a new cancer drug for the treatment of leukaemia.